Prior studies in Rett syndrome suggest potential non-cell-autonomous effects of MeCP2 deficiency on wild-type expressing cells in the brain, but these effects have been poorly characterized at a cellular and molecular level6–8. Here, MECP2 is linked to Rett syndrome.